Violation Detail
Standard Cited: 19101030 D02 I Bloodborne pathogens.
Inspection Nr: 1194099.015
Citation: 01002
Citation Type: Serious
Abatement Date: 08/31/2017 2
Initial Penalty: $9,959.00
Current Penalty: $7,000.00
Issuance Date: 04/10/2017
Nr Instances: 3
Nr Exposed: 44
Related Event Code (REC):
Gravity: 5
Report ID: 0524200
Contest Date:
Final Order: 05/04/2017
Emphasis:
Type | Latest Event | Event Date | Penalty | Abatement Due Date | Citation Type | Failure to Abate Inspection |
---|---|---|---|---|---|---|
Penalty | P: Petition to Mod Abatement | $7,000.00 | 08/31/2017 | Serious | ||
Penalty | I: Informal Settlement | 05/04/2017 | $7,000.00 | 05/04/2017 | Serious | |
Penalty | Z: Issued | 04/10/2017 | $9,959.00 | 05/04/2017 | Serious |
Text For Citation: 01 Item/Group: 002 Hazard:
29 CFR 1910.1030(d)(2)(i): Engineering and work practice controls were not used to eliminate or minimize employees exposure: a) Octapharma Plasma, Inc., Northlake, IL- On November 28, 2016, the employer did not ensure that engineering controls were used to eliminate or minimize employee exposures to blood borne pathogens when using the Greiner Bio-One Snappy tube holder. On October 27, 2016, an employee sustained a needle stick injury when disposing the used Greiner Bio-One Snappy tube holder. In accordance with 29 CFR 1903.19(d), abatement certification is required for this violation (using the CERTIFICATION OF CORRECTIVE ACTION WORKSHEET), and in addition, documentation demonstrating that abatement is complete must be included with your certification. This documentation may include, but is not limited to, evidence of the purchase or repair of the equipment, photographic or video evidence of abatement, or other written records.